National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation | Zendy

Jeffrey S. Dlott | Zendy; Roberta George | Zendy; Xiaohua Huang | Zendy; Mouneer A. Odeh | Zendy; Harvey W. Kaufman | Zendy; Jack Ansell | Zendy; Elaine M. Hylek | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation

Author(s) -

Jeffrey S. Dlott,

Roberta George,

Xiaohua Huang,

Mouneer A. Odeh,

Harvey W. Kaufman,

Jack Ansell,

Elaine M. Hylek

Publication year - 2014

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.113.002601

Subject(s) - medicine , warfarin , atrial fibrillation , stroke (engine) , emergency medicine , thrombosis , diagnosis code , therapeutic index , drug , population , mechanical engineering , environmental health , engineering , psychiatry

Anticoagulation control with warfarin, as assessed by the international normalized ratio (INR), is challenging. Time in the therapeutic range has been inversely correlated with major hemorrhage, thrombosis, and mortality. Quest Diagnostics offers standardized INR laboratory testing services to approximately half of US physician practices. To inform national stroke prevention strategies, we evaluated anticoagulation control in office-based community practices.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research